Company Filing History:
2 out of 1,863 
2 out of 3,539 
2 out of 15,475 
Years Active: 2020-2022
Title: Stacie Bulfer: Innovator in Allosteric Inhibitors
Introduction
Stacie Bulfer is a notable inventor based in Oakland, California. She has made significant contributions to the field of biochemistry, particularly in the development of allosteric inhibitors. With a total of two patents to her name, her work focuses on innovative methods to combat serious diseases.
Latest Patents
Stacie's latest patents include the development of phenyl indole allosteric inhibitors of p97 ATPase. These inventions are directed towards methods of inhibiting p97 and involve compounds and compositions that are useful in such methods. The diseases and conditions that can be treated with these compounds include, but are not limited to, cancer and neurodegenerative disorders that are susceptible to treatment by inhibition of p97.
Career Highlights
Throughout her career, Stacie has worked with prestigious institutions such as the University of Pittsburgh and the National Institutes of Health, a component of the U.S. Department of Health & Human Services. Her work in these organizations has allowed her to advance her research and contribute to significant scientific discoveries.
Collaborations
Stacie has collaborated with esteemed colleagues, including Donna Mary Huryn and Peter Wipf. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Stacie Bulfer's innovative work in the field of allosteric inhibitors showcases her dedication to addressing critical health challenges. Her contributions continue to pave the way for advancements in medical treatments.